Literature DB >> 13171947

Factors basic to the development of useful inhibitors of renal transport mechanisms.

K H BEYER.   

Abstract

Keywords:  KIDNEYS/physiology

Mesh:

Year:  1954        PMID: 13171947

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


× No keyword cloud information.
  8 in total

1.  Renal regulation of uric acid excretion in normal and gouty man; modification by uricosuric agents.

Authors:  A B GUTMAN; T F YU
Journal:  Bull N Y Acad Med       Date:  1958-05

2.  Probenecid in CSF and plasma of rabbits and dogs measured by radioimmunoassay.

Authors:  W L Shei; J Y Mu; R F Cunningham; Z H Israili; P G Dayton
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

3.  Renal handling of phenol red. III. Bidirectional transport.

Authors:  U Gerdes; J Kristensen; J V Møller; M I Sheikh
Journal:  J Physiol       Date:  1978-04       Impact factor: 5.182

4.  Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans.

Authors:  T B Vree; E W Beneken Kolmer
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

5.  Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster; M M Broekman
Journal:  Pharm World Sci       Date:  1993-10-15

6.  Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.

Authors:  T B Vree; E W Van Ewijk-Beneken Kolmer; E W Wuis; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

Review 7.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

8.  Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

Authors:  T B Vree; Y A Hekster; J E Damsma; M Tijhuis; W T Friesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.